XORTX Therapeutics XRTX
NASDAQ XRTX
$0.93 -0.06 (-6.05%)
At close: Oct 21, 2026 · 4:00 PM EDT

XORTX Therapeutics (XRTX) Current Leases (2022 - 2024)

Updated

XORTX Therapeutics (XRTX) reported Current Leases of $14,037 for the quarter ended Mar 31, 2024, up 22.0% from the prior quarter.

Analysis

XORTX Therapeutics (XRTX) Current Leases (2022 - 2024) Analysis & Trends

As of Dec 31, 2023, XORTX Therapeutics posted Current Leases of $11,510, down 82.6% from the prior year.

  • By year, Current Leases came in at $66,090 in the year ended Dec 31, 2022.
  • Five-year quarterly Current Leases spans a low of $11,510 in the quarter ended Dec 31, 2023 and a high of $66,090 in the quarter ended Dec 31, 2022.
  • Per Business Quant data, the three quarters before the quarter ended Mar 31, 2024 came in at $11,510 (quarter ended Dec 31, 2023), $28,512 (quarter ended Sep 30, 2023) and $45,185 (quarter ended Jun 30, 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 XORTX Therapeutics 893,236.25 -2.41 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 14,037.00
Dec 31, 2023 11,510.00
Sep 30, 2023 28,512.00
Jun 30, 2023 45,185.00
Dec 31, 2022 66,090.00
API Access

XORTX Therapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=XRTX&period=max&api_key=YOUR_API_KEY